# Serina Therapeutics, Inc.: Form 8-K, filed Jan 15, 2026

- Company: [Serina Therapeutics, Inc.](/companies/ser.md) (CIK 1708599)
- Form: 8-K
- Filed: 2026-01-15
- Accepted by EDGAR: Jan 15, 2026, 16:03 ET
- Period: 2026-01-09
- Accession: 0001708599-26-000003
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1708599/000170859926000003/ser-20260109.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1708599/000170859926000003/

## Items reported

- Item 3.01: Delisting notice
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1708599/000170859926000003/ser-20260109.htm

Filed Jan 15, 2026.
Source: SEC EDGAR, the filing index for accession 0001708599-26-000003. Last ingested by Listed: Nov 3, 2026, 18:22 ET. No prices; not investment advice.